Rheumatoid arthritis

Rheumatoid arthritis increases the risk of malignant neoplasm of bone and articular cartilage: a two-sample bidirectional mendelian randomization study

Arthritis Res TherPublished Two-sample bidirectional Mendelian randomisation study

Authors' conclusion

The findings of this study demonstrate that RA constitutes a significant risk factor for MNBAC.

Study context

Population
GWAS summary data: Rheumatoid arthritis (RA) from IEU OpenGWAS database; Benign neoplasm of bone and articular cartilage (BNBAC) and malignant neoplasm of bone and articular cartilage (MNBAC) from the Finnish consortium
Comparison
Genetically predicted RA vs benign (BNBAC) and malignant (MNBAC) neoplasm of bone and articular cartilage, and reverse
Outcome
Causal association between RA and BNBAC and MNBAC
Methodological detailsGWAS summary data, eight Mendelian randomization (MR) methods (random-effects inverse variance weighted (IVW), MR Egger, weighted median, simple mode, weighted mode, maximum likelihood, penalized weighted median, fixed effects IVW)
  • GWAS summary data
  • Eight MR methods (random-effects IVW, MR Egger, weighted median, simple mode, weighted mode, maximum likelihood, penalized weighted median, fixed effects IVW)

Main finding

As reported in the abstract

RAOdds ratio (95% CI)P value
Outcome BNBAC; no significant genetic association
0.971(0.904–1.044)
P = 0.427
Outcome MNBAC; positive genetic association
1.413(1.144–1.745)
P = 0.001

Further findings

Reverse MR: BNBAC and MNBAC on RA

OR (95% CI)P value
BNBACOutcome RA1.041 (0.994–1.091)P = 0.088
MNBACOutcome RA1.013 (0.995–1.031)P = 0.168

Sensitivity analyses

No heterogeneity, horizontal pleiotropy or outliers; effect not driven by a single single-nucleotide polymorphism (SNP); data normally distributed

Original publication

Rheumatoid arthritis increases the risk of malignant neoplasm of bone and articular cartilage: a two-sample bidirectional mendelian randomization study. Arthritis Res Ther. Published 13 November 2023. doi:10.1186/s13075-023-03205-5

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.